Form 8-K - Current report:
SEC Accession No. 0001178879-20-000025
Filing Date
2020-06-08
Accepted
2020-06-08 16:41:35
Documents
14
Period of Report
2020-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fold-20200604.htm   iXBRL 8-K 54734
  Complete submission text file 0001178879-20-000025.txt   198010

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20200604.xsd EX-101.SCH 2607
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20200604_cal.xml EX-101.CAL 742
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20200604_def.xml EX-101.DEF 1679
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20200604_lab.xml EX-101.LAB 24266
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20200604_pre.xml EX-101.PRE 12678
14 EXTRACTED XBRL INSTANCE DOCUMENT fold-20200604_htm.xml XML 10926
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 20949578
SIC: 2834 Pharmaceutical Preparations